2-(n,n-dimethylamino)-6,7-dihydroxytetralin has been researched along with (5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol in 2 studies
Studies (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Trials (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Studies ((5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol) | Trials ((5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol) | Recent Studies (post-2010) ((5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol) |
---|---|---|---|---|---|
46 | 0 | 0 | 15 | 0 | 8 |
Protein | Taxonomy | 2-(n,n-dimethylamino)-6,7-dihydroxytetralin (IC50) | (5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol (IC50) |
---|---|---|---|
D | Rattus norvegicus (Norway rat) | 0.0043 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.511 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brusniak, MY; Neve, KA; Pearlman, RS; Wilcox, RE | 1 |
Brusniak, MY; DuRand, C; Ginsburg, B; Neve, KA; Pearlman, RS; Starr, S; Teeter, M; Tseng, T; Wilcox, RE | 1 |
2 other study(ies) available for 2-(n,n-dimethylamino)-6,7-dihydroxytetralin and (5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol
Article | Year |
---|---|
Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
Topics: Animals; Cell Line; Chlorocebus aethiops; Computer Graphics; Dopamine; Dopamine Agonists; Glioma; Humans; Kinetics; Models, Molecular; Receptors, Dopamine D1; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Topics: Animals; Binding Sites; Databases, Factual; Dopamine Agonists; Humans; Ligands; Macaca mulatta; Models, Molecular; Molecular Conformation; Protein Structure, Secondary; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |